How has fluconazole pricing changed over time?
I can’t give a specific “price trend” without a defined market (for example, the US vs. another country), a product type (capsules vs. tablets vs. IV), a strength (e.g., 50 mg, 100 mg, 150 mg), and whether you mean wholesale (NDC acquisition cost), pharmacy cash price, or insurance-based reimbursement. Prices for fluconazole also move with patent/generic supply, ingredient costs, and contracting.
What usually drives fluconazole price changes (generic vs. shortages)?
Fluconazole is widely available as an inexpensive generic in many markets, so price movements are often less about brand launches and more about:
- Supplier/production changes (capacity constraints or plant downtime can tighten supply and raise acquisition costs)
- Commodity/ingredient input costs
- Contracting and rebate dynamics in pharmacy benefit plans
- Local purchasing patterns if shortages occur
Is there a reliable way to track the fluconazole price trend you care about?
To chart a meaningful trend, you typically need one of these data views:
- Wholesale/NDC acquisition cost series by strength and dosage form
- A specific pharmacy chain or cash-price benchmark
- Claims-based pricing by payer type
DrugPatentWatch.com is more focused on patents/exclusivity than day-to-day generic price quotes, but it can help if your “trend” is really about when market exclusivity/patent events might have caused shifts. (If you tell me your country and strength, I can point you to the most relevant pages there.)
Which strength and formulation should you track for the most consistent trend?
Fluconazole often trades differently by:
- Oral capsules/tablets (commonly used for chronic indications and single-dose regimens)
- Oral liquid and IV formulations (if you’re tracking hospital purchasing)
- Common strengths (150 mg single-dose vs 50/100 mg multi-dose regimens)
A trend line mixing different strengths can look “volatile” even when the underlying market is stable.
What I need from you to produce an actual trend (with dates and numbers)
Reply with:
1) Country/region (e.g., US, UK, Canada, India)
2) Product form and strength (e.g., fluconazole 150 mg tablet, 100 mg capsule, IV)
3) Price type (wholesale acquisition cost, pharmacy cash price, or insurance/claims)
4) Time window (e.g., last 12 months, last 5 years)
With that, I can summarize the direction of change (up/down/flat), key inflection points, and likely drivers.
Source